The role of vaccines in cancer prevention.

作者: Samir N. Khleif , Helen Frederickson

DOI: 10.1007/978-1-4615-1657-6_12

关键词:

摘要: From 1796, when Edward Jenner infected a young boy with cowpox in hopes of preventing smallpox, to the present day, vaccinations have changed incidence many diseases worldwide. The history immunology actually predates ancient China, India and Persia. observation that recovery from particular disease rendered people “immune” second episode same disease, led Chinese try prevent smallpox by exposing uninfected pustule samples obtained lesions. then improved safety vaccination using different, but similar, virus vaccinate rather than him authentic virus. His observations milkmaids who had developed lesions did not develop “vaccinate” twenty-three other publish his findings 1801 (1). This initial experiment serves as an important foundation modern day immunology, served popularize term “vaccine”, which is derived Latin word “vacca”, means cow. Years later, Louis Pasteur, advanced germ theory infection, was able prove could be prevented exposure “weakened” germs, only caused harmless infections. theories supported development rabies vaccine.

参考文章(153)
Yutaka Kawakami, Michael I. Nishimura, Nicholas P. Restifo, Suzanne L. Topalian, Bert H. OʼNeil, Joel Shilyansky, John R. Yannelli, Steven A. Rosenberg, T-Cell Recognition of Human Melanoma Antigens Journal of Immunotherapy. ,vol. 14, pp. 88- 93 ,(1993) , 10.1097/00002371-199308000-00002
L. P. Chen, E. K. Thomas, S. L. Hu, I. Hellstrom, K. E. Hellstrom, Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 110- 114 ,(1991) , 10.1073/PNAS.88.1.110
Q. Y. Yao, A. B. Rickinson, M. A. Epstein, A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. International Journal of Cancer. ,vol. 35, pp. 35- 42 ,(1985) , 10.1002/IJC.2910350107
E. Pareja, R. Tobes, J. Martin, A. Nieto, The tetramer model: a new view of class II MHC molecules in antigenic presentation to T cells Tissue Antigens. ,vol. 50, pp. 421- 428 ,(1997) , 10.1111/J.1399-0039.1997.TB02896.X
H. Popper, L. Roth, R. H. Purcell, B. C. Tennant, J. L. Gerin, Hepatocarcinogenicity of the woodchuck hepatitis virus Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 866- 870 ,(1987) , 10.1073/PNAS.84.3.866
Keith D. Wilkinson, Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Seminars in Cell & Developmental Biology. ,vol. 11, pp. 141- 148 ,(2000) , 10.1006/SCDB.2000.0164
R. L. Ferrero, J. M. Thiberge, I. Kansau, N. Wuscher, M. Huerre, A. Labigne, The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 6499- 6503 ,(1995) , 10.1073/PNAS.92.14.6499
Samir N. Khleif, Scott I. Abrams, J Michael Hamilton, Elke Bergmann-Leitner, Alice Chen, Anne Bastian, Sarah Bernstein, Yoomie Chung, Carmen J. Allegra, Jeffrey Schlom, A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumors. Journal of Immunotherapy. ,vol. 22, pp. 155- 165 ,(1999) , 10.1097/00002371-199903000-00007